Regorafenib Hydrochloride
Product #：
TL0708
Image
SKU-Pack Size
Stock
Price($)
Quantity
-
-
TL0708-25MG
In stock
91.6
-
+
TL0708-100MG
In stock
225.4
-
+
TL0708-250MG
In stock
414
-
+
Details
l General Information |
Product Name | Regorafenib Hydrochloride |
General description | Regorafenib Hydrochloride is an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. |
Synonym | 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; hydrochloride; BAY73-4506 hydrochloride |
Purity | ≥99.0%(HPLC) | CAS Number | 835621-07-3 |
Formula | C21H16Cl2F4N4O3 | Molecular Weight | 519.278 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
l Biological Information |
Biochem/Physiol Actions | Regorafenib Hydrochloride is an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. |
l Packaging & Storage |
Packaging | 25mg; 100mg; 250mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
